Cyril Llamoso is an Infectious Disease physician affiliated with Merck & Co.. OpenAlex indexes 53 publications with 925 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
450 Clarkson Ave
Suite A
Brooklyn, NY 112032056
Telephone
718-270-1432Registry record last updated 8 Jul 2007.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Resistance Analysis of Weekly Islatravir Plus Lenacapavir in People With HIV at 48 Weeks
JAIDS Journal of Acquired Immune Deficiency Syndromes
2026 - A Phase 1 Study to Evaluate the Potential Drug–Drug Interaction Between Islatravir and Lenacapavir
The Journal of Clinical Pharmacology
2026 - Evaluation of Relative Bioavailability and Food Effect of a Fixed‐Dose Combination Tablet of Islatravir and Lenacapavir
The Journal of Clinical Pharmacology
2026 - Modélisation pharmacocinétique d'une dose hebdomadaire manquée avec l'association orale islatravir + lénacapavir
Médecine et Maladies Infectieuses Formation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Lubiniecki, MD
Merck & Co.
Luther Clark, MD
Merck & Co.
Alfred Saah, MD
Merck & Co.
Keith Kaufman, MD
Merck & Co.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”